Imidazoli(di)ne compounds interact with the phencyclidine site of NMDA receptors in the rat brain

The effects of several imidazoli(di)ne compounds on the binding of the non-competitive NMDA receptor antagonist [ 3H](+)-MK-801 (dizocilpine) to rat brain membranes were studied. These compounds fully inhibit radioligand binding with potencies in the micromolar range. The obtained profile of drug af...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of pharmacology Vol. 310; no. 2; pp. 273 - 276
Main Authors Olmos, Gabriel, Ribera, Joan, García-Sevilla, Jesús A.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 29.08.1996
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The effects of several imidazoli(di)ne compounds on the binding of the non-competitive NMDA receptor antagonist [ 3H](+)-MK-801 (dizocilpine) to rat brain membranes were studied. These compounds fully inhibit radioligand binding with potencies in the micromolar range. The obtained profile of drug affinity correlated well with the potency of the same compounds promoting insulin release by blocking ATP-sensitive K + channels in the rat insulinoma cell line RIN-5AH. It is suggested that imidazoli(di)ne compounds interact with cation channels sharing a common phencyclidine binding site (e.g. NMDA receptors, K + channels and nicotinic acetylcholine receptors) and that this could be the basis of some biological effects of imidazoli(di)nes.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0014-2999
1879-0712
DOI:10.1016/0014-2999(96)00519-5